Related references
Note: Only part of the references are listed.Oral anticoagulant and reduced risk of dementia in patients with atrial fibrillation: A population-based cohort study
Pajaree Mongkhon et al.
HEART RHYTHM (2020)
Real-World Adherence and Persistence to Direct Oral Anticoagulants in Patients With Atrial Fibrillation A Systematic Review and Meta-Analysis
Aya F. Ozaki et al.
CIRCULATION-CARDIOVASCULAR QUALITY AND OUTCOMES (2020)
Atrial Fibrillation and Cognitive Function JACC Review Topic of the Week
Hans-Christoph Diener et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2019)
The validity of dementia diagnoses in routinely collected electronic health records in the United Kingdom: A systematic review
Luke A. McGuinness et al.
PHARMACOEPIDEMIOLOGY AND DRUG SAFETY (2019)
Less dementia and stroke in low-risk patients with atrial fibrillation taking oral anticoagulation
Leif Friberg et al.
EUROPEAN HEART JOURNAL (2019)
Getting to the Heart of Alzheimer Disease
Joshua M. Tublin et al.
CIRCULATION RESEARCH (2019)
Oral anticoagulants and risk of dementia: A systematic review and meta analysis of observational studies and randomized controlled trials
Pajaree Mongkhon et al.
NEUROSCIENCE AND BIOBEHAVIORAL REVIEWS (2019)
Less dementia with oral anticoagulation in atrial fibrillation
Leif Friberg et al.
EUROPEAN HEART JOURNAL (2018)
Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
Laila Staerk et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Lifetime risk of atrial fibrillation according to optimal, borderline, or elevated levels of risk factors: cohort study based on longitudinal data from the Framingham Heart Study
Laila Staerk et al.
BMJ-BRITISH MEDICAL JOURNAL (2018)
Effectiveness and Safety of Oral Anticoagulants Among Nonvalvular Atrial Fibrillation Patients The ARISTOPHANES Study
Gregory Y. H. Lip et al.
STROKE (2018)
Atrial Fibrillation, Cognitive Decline, and Dementia: an Epidemiologic Review
Mozhu Ding et al.
CURRENT EPIDEMIOLOGY REPORTS (2018)
The Tasmanian atrial fibrillation study: Transition to direct oral anticoagulants 2011-2015
Endalkachew Admassie Alamneh et al.
CARDIOVASCULAR THERAPEUTICS (2017)
Long-Term Population-Based Cerebral Ischemic Event and Cognitive Outcomes of Direct Oral Anticoagulants Compared With Warfarin Among Long-term Anticoagulated Patients for Atrial Fibrillation
Victoria Jacobs et al.
AMERICAN JOURNAL OF CARDIOLOGY (2016)
Data Resource Profile: Clinical Practice Research Datalink (CPRD)
Emily Herrett et al.
INTERNATIONAL JOURNAL OF EPIDEMIOLOGY (2015)
Vascular dysfunction in the pathogenesis of Alzheimer's disease - A review of endothelium-mediated mechanisms and ensuing vicious circles
Luigi Yuri Di Marco et al.
NEUROBIOLOGY OF DISEASE (2015)
Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
Christian T. Ruff et al.
LANCET (2014)
Cognitive Impairment Associated With Atrial Fibrillation A Meta-analysis
Shadi Kalantarian et al.
ANNALS OF INTERNAL MEDICINE (2013)
Atrial fibrillation and the risk of incident dementia: A meta-analysis
Pasquale Santangeli et al.
HEART RHYTHM (2012)
Cerebral blood flow in Alzheimer's disease
Alex E. Roher et al.
VASCULAR HEALTH AND RISK MANAGEMENT (2012)
Atrial fibrillation and incidence of dementia A systematic review and meta-analysis
C. S. Kwok et al.
NEUROLOGY (2011)
Apixaban versus Warfarin in Patients with Atrial Fibrillation
Christopher B. Granger et al.
NEW ENGLAND JOURNAL OF MEDICINE (2011)
Competing Risk Regression Models for Epidemiologic Data
Bryan Lau et al.
AMERICAN JOURNAL OF EPIDEMIOLOGY (2009)
Share Paper
